Literature DB >> 24630033

Clinical and video urodynamic characteristics of adult women with dysfunctional voiding.

Yih-Chou Chen1, Hann-Chorng Kuo2.   

Abstract

BACKGROUND/
PURPOSE: Dysfunctional voiding (DV) is an abnormality of bladder emptying in neurologically normal individuals where the external sphincter activity increases during voiding. This study investigated the clinical presentations and videourodynamic characteristics of adult women with DV.
METHODS: A total of 1605 women with lower urinary tract symptoms (LUTS) were investigated with videourodynamic (VUD) studies from 1997 to 2010. The clinical urinary symptoms and VUD characteristics of DV were compared with a group of urodynamically normal controls. Antimuscarinic or alpha-blocker treatment according to the chief complaint of storage or voiding LUTS was respectively given.
RESULTS: There were 168 women diagnosed with DV. Detrusor overactivity (DO) occurred in 69% of women with DV. Patients with DV had significantly lower cystometric bladder capacity, higher detrusor pressure, lower maximum flow rate, and larger post-void residual volume than the controls. A total of 114 (67.9%) patients had storage symptoms and 54 (32.1%) had voiding symptoms as their chief complaints among those with DV. Among them, urinary frequency (n = 69, 41.1%) was the most common chief complaint, followed by dysuria (n = 53, 32.1%), and urgency incontinence (n = 26, 15.5%). The incidence of urgency incontinence and dysuria were significantly greater than that in the control group, however, the incidence of frequency, urgency, or nocturia showed no significant difference between DV and control groups. The success rates were 41.2% (n = 47) for antimuscarinic therapy and 51.9% (n = 28) for alpha-blocker therapy in patients with storage and voiding LUTS, respectively (p = 0.366).
CONCLUSION: DO and storage LUTS commonly occurred in women with DV, suggesting DO could be one of the etiology in the pathophysiology of DV. VUD studies yielded a high diagnostic rate for DV in women with LUTS.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Keywords:  detrusor overactivity; dysfunctional voiding; video urodynamics; women

Mesh:

Substances:

Year:  2012        PMID: 24630033     DOI: 10.1016/j.jfma.2012.04.008

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  7 in total

1.  Obstructive patterns in videourodynamic studies predict responses of female dysfunctional voiding treated with or without urethral botulinum toxin injection: a long-term follow-up study.

Authors:  Po-Ming Chow; Sheng-Mou Hsiao; Hann-Chorng Kuo
Journal:  Int Urogynecol J       Date:  2020-06-18       Impact factor: 2.894

Review 2.  Dysfunctional voiding: Challenges of disease transition from childhood to adulthood.

Authors:  Fannie Morin; Hamed Akhavizadegan; Alex Kavanagh; Katherine Moore
Journal:  Can Urol Assoc J       Date:  2018-04       Impact factor: 1.862

Review 3.  Bladder outlet obstruction in women: functional causes.

Authors:  Ashley B King; Howard B Goldman
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

4.  Videourodynamic Studies of Women with Voiding Dysfunction.

Authors:  Sheng-Mou Hsiao; Ho-Hsiung Lin; Hann-Chorng Kuo
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

5.  Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions.

Authors:  Yu-Khun Lee; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2019-08-23       Impact factor: 4.546

6.  Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women.

Authors:  Yuan-Hong Jiang; Cheng-Ling Lee; Sheng-Fu Chen; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2021-05-19       Impact factor: 4.546

7.  Therapeutic efficacy of biofeedback pelvic floor muscle exercise in women with dysfunctional voiding.

Authors:  Ching-Hsiang Chiang; Yuan-Hong Jiang; Hann-Chorng Kuo
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.